SCHEMBL22978573

SCHEMBL22978573

[CH2]Cc1cnc(Cl)c(OCC)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
ENPP1 P22413 1/20 0.36
AOC3 Q16853 2/20 0.34
MAPK1 P28482 4/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
CYP3A4 P08684 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
ADRA2A P08913 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
CHRM1 P11229 1/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34
DRD1 P21728 1/20 0.34
TBXA2R P21731 1/20 0.34
PDE4A P27815 1/20 0.34
ADRA1A P35348 1/20 0.34
DRD3 P35462 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27677964 0.84 NPC1 (0.40) ALDH1A1ENPP1SMN1; SMN2TDP1MEN1
SCHEMBL17696409 0.76 GRM5 (0.44) ALDH1A1ENPP1AOC3MAPK1SMN1; SMN2
SCHEMBL189068 0.74 GRM5 (0.44) ALDH1A1ENPP1AOC3SMN1; SMN2MEN1
SCHEMBL20606819 0.74 KDM4E (0.44) ALDH1A1ENPP1AOC3MAPK1SMN1; SMN2
SCHEMBL4631483 0.73 PTGS2 (0.34) TDP1PDE4APOLBPDE4DNPC1
SCHEMBL17693906 0.71 ALDH1A1 (0.40) ALDH1A1ENPP1AOC3CYP1A2TSHR
SCHEMBL6775456 0.71 TSHR (0.48) ALDH1A1SMN1; SMN2MEN1LMNATSHR
SCHEMBL22641245 0.70 PTGS2 (0.48) ALDH1A1ENPP1SMN1; SMN2TDP1MEN1
SCHEMBL2853131 0.70 ALDH1A1 (0.32) ALDH1A1TDP1KDM4EHPGD
SCHEMBL31381976 0.70 NPSR1 (0.55) ALDH1A1MAPK1CYP3A4TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021026672-A1 HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS NOVARTIS AG (CH) 2021-02-18 WO disclosed